Defunct Company
Total Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
475
NCT01873053
A 12 Week, Phase II Trial to Evaluate the Efficacy and Safety of WIN-34B in Patients With Osteoarthritis of the Knee
Phase: Phase 2
Role: Collaborator
Start: Apr 30, 2013
Completion: Aug 31, 2014
NCT05068024
A Study of FWD1509 in Adults With Non-Small Cell Lung Cancer
Phase: Phase 1/2
Role: Lead Sponsor
Start: Aug 23, 2021
Completion: Dec 30, 2025
NCT06064812
A Phase I Clinical Trial of FWD1802 in Patients With ER+/HER2- BC.
Phase: Phase 1
Start: Sep 12, 2023
Completion: Feb 28, 2026
NCT07002177
A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC
Start: Jun 1, 2025
Completion: Nov 1, 2028